medical device
| Year | Client | Period | Income | Expenses | Doc |
|---|---|---|---|---|---|
| 2015 | OSIRIS THERAPEUTICS |
3rd Quarter (July 1 - Sep 30) AMENDED |
— | $50,000 | |
| 2015 | OSIRIS THERAPEUTICS |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
— | $50,000 | |
| 2015 | OSIRIS THERAPEUTICS |
1st Quarter (Jan 1 - Mar 31) AMENDED |
— | $50,000 | |
| 2015 | OSIRIS THERAPEUTICS |
1st Quarter (Jan 1 - Mar 31) AMENDED |
— | — | |
| 2015 | OSIRIS THERAPEUTICS |
1st Quarter (Jan 1 - Mar 31) Registration |
— | — |
| Client | Filings | Total Income |
|---|---|---|
| OSIRIS THERAPEUTICS | 5 | — |
| Name | Disclosed Prior Position |
|---|---|
| THERESA KATHLEEN DIXON | General Manager, Market Access |